Thomas Defay

671 total citations
4 papers, 22 citations indexed

About

Thomas Defay is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Thomas Defay has authored 4 papers receiving a total of 22 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Genetics and 1 paper in Genetics. Recurrent topics in Thomas Defay's work include Genomics and Rare Diseases (3 papers), CRISPR and Genetic Engineering (2 papers) and Genomic variations and chromosomal abnormalities (1 paper). Thomas Defay is often cited by papers focused on Genomics and Rare Diseases (3 papers), CRISPR and Genetic Engineering (2 papers) and Genomic variations and chromosomal abnormalities (1 paper). Thomas Defay collaborates with scholars based in United States, Netherlands and Japan. Thomas Defay's co-authors include Jerry Vockley, Timothy W. Yu, Lex M. Cowsert, Annemieke Aartsma‐Rus, R. Rodney Howell, Amy Brower, Amy Gaviglio, Amy L. McGuire, Mark W. Skinner and Melissa Wasserstein and has published in prestigious journals such as Blood and American Journal of Medical Genetics Part C Seminars in Medical Genetics.

In The Last Decade

Thomas Defay

3 papers receiving 20 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Defay United States 3 18 10 4 3 3 4 22
Lisa Salz United States 4 15 0.8× 8 0.8× 3 0.8× 2 0.7× 1 0.3× 4 25
Jordi Corominas Galbany Netherlands 2 20 1.1× 11 1.1× 3 0.8× 2 0.7× 5 33
Mitchell Conery United States 4 12 0.7× 16 1.6× 3 1.0× 4 1.3× 5 31
Britton Zuccarelli United States 3 11 0.6× 9 0.9× 3 0.8× 8 2.7× 5 21
Joe Gleeson United States 3 12 0.7× 7 0.7× 3 0.8× 1 0.3× 4 26
Catriona L. K. Barnes Germany 3 17 0.9× 9 0.9× 1 0.3× 2 0.7× 4 32
Jaime Barea United States 2 6 0.3× 6 0.6× 8 2.0× 2 0.7× 3 21
Mohammed M. Saleh Saudi Arabia 3 12 0.7× 17 1.7× 11 2.8× 2 0.7× 1 0.3× 4 28
Stephen Hellens United Kingdom 3 21 1.2× 10 1.0× 1 0.3× 2 0.7× 4 32
Marie Falkenberg Smeland Norway 3 8 0.4× 10 1.0× 2 0.5× 8 2.7× 4 24

Countries citing papers authored by Thomas Defay

Since Specialization
Citations

This map shows the geographic impact of Thomas Defay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Defay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Defay more than expected).

Fields of papers citing papers by Thomas Defay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Defay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Defay. The network helps show where Thomas Defay may publish in the future.

Co-authorship network of co-authors of Thomas Defay

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Defay. A scholar is included among the top collaborators of Thomas Defay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Defay. Thomas Defay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Augustine, Erika F., Amy Brower, Thomas Defay, et al.. (2023). Data sharing to advance gene‐targeted therapies in rare diseases. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 193(1). 87–98. 7 indexed citations
2.
Vockley, Jerry, Annemieke Aartsma‐Rus, Jennifer L. Cohen, et al.. (2022). Whole‐genome sequencing holds the key to the success of gene‐targeted therapies. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 193(1). 19–29. 10 indexed citations
3.
Doan, Quan V., Jennifer Evans, Thomas Defay, et al.. (2022). Evaluation of the Path to Diagnosis and Time to Treatment in Patients with Light-Chain Amyloidosis Using the Komodo Claims Database. Blood. 140(Supplement 1). 4330–4331.
4.
Vockley, Jerry, Thomas Defay, Aaron J. Goldenberg, & Amy Gaviglio. (2022). Scaling genetic resources: New paradigms for diagnosis and treatment of rare genetic disease. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 193(1). 77–86. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026